LLYQ3 20261/4Estimate vs Actual
Earnings per Share
$7.48
+ 13.2% vs Estimate
Surprise as recorded in the analysis; the estimate itself is not on the calendar.
Eli Lilly and Co Q3 2026 · Story
Read the quarter card by card, ready to share.
LLYQ3 20261/4LLYQ3 20262/4Guidance
Full-Year Revenue
- Company Guidance
- 91 – 92 B
- Market Estimate
- 88.6 B
3.3% Above Estimate ▲
Full-Year Adjusted EPS
- Company Guidance
- 35 – 36 $
Midpoint Lowered 1.4% ▼
Full-Year Performance Margin
- Company Guidance
- 52.0% – 52.5%
Raised 2.5 Points ▲
LLYQ3 20263/4In 30 Seconds
Revenue rose 39% to $24.40 billion, beating expectations by 7.9%, and adjusted EPS of $7.48 came in 13.2% above estimates.
- Full-year revenue guidance rose to $91-92 billion, though about $900 million of quarterly revenue came from one-time benefits.
- The stock rose 6.6% intraday on strong volume growth and the raised outlook.
First point of the analysis's “In 30 Seconds”.
Full AnalysisLLYQ3 20264/4Score
82/ 100
ViewBUY
Not Investment Advice